Related Experiment Video

Updated: May 8, 2025

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

8.8K

Fever Prevention in Acute Vascular Brain Injury

Tomoya Okazaki1

  • 1Department of Emergency and Critical Care Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, Japan.

JAMA
|January 22, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
09:14

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

2.2K
An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke
12:19

An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke

Published on: March 11, 2018

11.3K

Related Experiment Videos

Last Updated: May 8, 2025

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

8.8K
Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
09:14

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

2.2K
An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke
12:19

An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke

Published on: March 11, 2018

11.3K

Related Concept Videos

Increased Body Temperature01:25

Increased Body Temperature

611
A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
611
Methods of reducing fever01:22

Methods of reducing fever

610
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
610
Decreased Body Temperature01:29

Decreased Body Temperature

573
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
573
The Blood-brain Barrier00:49

The Blood-brain Barrier

46.2K
Overview
46.2K

Articles linked to this work by shared authors, journal, and citation graph.

Electrocardiographic Changes Related to Targeted Temperature Management in Brugada Syndrome: A Case Report.

Clinical practice and cases in emergency medicine·2026

Comparing Clinical and Radiological Outcomes for a Three-Dimensional Printed Highly Porous Cup and a Hydroxyapatite-Coated Non-Highly Porous Cup in Total Hip Arthroplasty Using Propensity Score Matching.

The Journal of arthroplasty·2026

Optimizing preoperative planning for total hip arthroplasty using random forest models to predict stem size and compatibility.

BMC musculoskeletal disorders·2026

Polymyxin B Hemoperfusion for Patients With Septic Shock Requiring High-Dose Norepinephrine: A Multicenter Prospective Cohort Study.

Critical care explorations·2025

Denosumab associated with accelerated progression of abdominal aortic calcification among patients on dialysis.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025

HEMODYNAMIC RESPONSE BY POLYMYXIN B HEMOPERFUSION AND ITS CLINICAL OUTCOMES IN PATIENTS WITH REFRACTORY SEPTIC SHOCK: A POST-HOC SUBANALYSIS OF PROSPECTIVE COHORT STUDY.

Shock (Augusta, Ga.)·2025

Predictive Utility of Coronary Artery Calcium Score Added to the PREVENT Atherosclerotic Cardiovascular Disease Equations.

JAMA·2026

Postural Orthostatic Tachycardia Syndrome (POTS): A Review.

JAMA·2026

Fragrance-Free Policies in Practice: Identifying Perceived Implementation Gaps Through Lived Experience in a Qualitative-Dominant Mixed-Methods Study.

International journal of environmental research and public health·2026

Co-Creating in Close Collaboration with Community Stakeholders: Transferable Lessons Learned from the Development of a Group-Based Intervention for Intimate Partner Violence (IPV) Survivors in Sweden.

International journal of environmental research and public health·2026

Protein Disulfide Isomerase A6 (PDIA6) Restrains Heat-Induced Oxidative Damage in Haemocytes of the Pacific Oyster (Crassostrea gigas).

Antioxidants (Basel, Switzerland)·2026

The Next Generation of Trauma-Informed Care: Supporting Early Relational Health in Primary Care Pediatrics.

Pediatric annals·2026

Human papillomavirus research in Gulf Cooperation Council (GCC) countries - current evidence, genotypes, and priority gaps: A scoping review.

Journal of infection and public health·2026

Cleaning and Disinfecting Public Transportation Vehicles Against Respiratory Infectious Diseases in Lebanon: A Cross-Sectional Study.

Risk management and healthcare policy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us